Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

DALACIN T 1%

PFIZER CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is DALACIN T 1% discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that DALACIN T 1% has been permanently discontinued (last updated March 11, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is DALACIN T 1% not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength1%
Last updated2019-03-11

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DALACIN C PHOSPHATE

PFIZER CANADA ULC

150MG · DIN 00260436

Different strengthSame dosage formDifferent routeNo current shortage

CLINDAMYCIN INJECTION, USP

ABBOTT LABORATORIES, LIMITED

150MG · DIN 02130866

Different strengthSame dosage formDifferent routeNo current shortage

DALACIN C FLAVOURED GRANULES

PFIZER CANADA ULC

75MG · DIN 00225851

Different strengthDifferent dosage formDifferent routeNo current shortage

DALACIN C 150 MG

PFIZER CANADA ULC

150MG · DIN 00030570

Different strengthDifferent dosage formDifferent routeNo current shortage

RATIO-CLINDAMYCIN CAPSULES - 300MG

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

300MG · DIN 02192659

Different strengthDifferent dosage formDifferent routeNo current shortage

CLINDAMYCIN PHOSPHATE INJECTION USP LIQ

LYPHOMED, DIVISION OF FUJISAWA CANADA INC.

150MG · DIN 02051826

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00582301

Strength

1%

Dosage Form

SOLUTION

Route

TOPICAL

Active Ingredient

CLINDAMYCIN

See all CLINDAMYCIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History